Detalhe da pesquisa
1.
Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives.
JCO Precis Oncol
; 8: e2300117, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207228
2.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Clin Cancer Res
; 29(7): 1317-1331, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602782
3.
Docetaxel in the treatment of children with refractory or relapsed hepatoblastoma.
J Pediatr Hematol Oncol
; 34(7): e295-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22469940
4.
Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations.
Front Pediatr
; 10: 957944, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467471
5.
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
JCO Precis Oncol
; 6: e2100534, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265118
6.
Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.
Eur J Cancer
; 162: 209-220, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933802
7.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
J Clin Oncol
; 39(30): 3377-3390, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115544
8.
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma.
EBioMedicine
; 59: 102971, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846370
9.
In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis.
Cancer Res
; 79(20): 5382-5393, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405846
10.
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.
Eur J Cancer
; 121: 224-235, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543384
11.
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Expert Opin Drug Discov
; 12(8): 801-811, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28604107
12.
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma.
Nucl Med Commun
; 37(5): 466-72, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813989